ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05205	Proteoglycans in cancer	28/201	271/7206	1.36631930193e-09
ko04668	TNF signaling pathway	18/201	120/7206	4.35603035671e-09
ko04512	ECM-receptor interaction	14/201	79/7206	2.76998477873e-08
ko04657	IL-17 signaling pathway	14/201	87/7206	9.89193909666e-08
ko04380	Osteoclast differentiation	17/201	134/7206	1.52196155417e-07
ko04933	AGE-RAGE signaling pathway in diabetic complications	17/201	135/7206	1.69893478388e-07
ko05200	Pathways in cancer	34/201	492/7206	5.93633793359e-07
ko04060	Cytokine-cytokine receptor interaction	19/201	191/7206	1.31043126795e-06
ko04510	Focal adhesion	21/201	240/7206	2.90009491747e-06
ko04974	Protein digestion and absorption	12/201	96/7206	1.27632270831e-05
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	10/201	79/7206	6.13828500306e-05
ko04064	NF-kappa B signaling pathway	11/201	96/7206	6.70218648126e-05
ko05160	Hepatitis C	14/201	153/7206	8.65507862291e-05
ko04151	PI3K-Akt signaling pathway	25/201	390/7206	8.80017136967e-05
ko05146	Amoebiasis	11/201	99/7206	8.90506194804e-05
ko05206	MicroRNAs in cancer	15/201	177/7206	0.00011622486509
ko04670	Leukocyte transendothelial migration	13/201	151/7206	0.000285321662463
ko05418	Fluid shear stress and atherosclerosis	14/201	173/7206	0.000318349520307
ko05224	Breast cancer	14/201	174/7206	0.000337825034902
ko04912	GnRH signaling pathway	11/201	122/7206	0.000566891375313
ko04611	Platelet activation	13/201	163/7206	0.000598617410073
ko01522	Endocrine resistance	11/201	124/7206	0.000650815798522
ko05166	HTLV-I infection	19/201	292/7206	0.000698650599098
ko05222	Small cell lung cancer	9/201	89/7206	0.000788423741183
ko04621	NOD-like receptor signaling pathway	12/201	157/7206	0.00140401311259
ko05100	Bacterial invasion of epithelial cells	9/201	99/7206	0.00168995012303
ko04640	Hematopoietic cell lineage	7/201	64/7206	0.001911602896
ko05131	Shigellosis	8/201	82/7206	0.00193795425379
ko05219	Bladder cancer	6/201	48/7206	0.00201977731384
ko04015	Rap1 signaling pathway	17/201	278/7206	0.00221279158756
ko04390	Hippo signaling pathway	13/201	188/7206	0.00222273822044
ko04660	T cell receptor signaling pathway	10/201	124/7206	0.00234521538848
ko04012	ErbB signaling pathway	9/201	109/7206	0.00327788414647
ko04072	Phospholipase D signaling pathway	13/201	197/7206	0.0033443492744
ko05120	Epithelial cell signaling in Helicobacter pylori infection	8/201	92/7206	0.00399473212247
ko04210	Apoptosis	12/201	180/7206	0.00438360759827
ko04931	Insulin resistance	10/201	137/7206	0.00482290856544
ko04370	VEGF signaling pathway	7/201	77/7206	0.0054611412417
ko05132	Salmonella infection	8/201	98/7206	0.00586197113082
ko04916	Melanogenesis	10/201	142/7206	0.00619733476228
ko05410	Hypertrophic cardiomyopathy (HCM)	8/201	100/7206	0.00661270178872
ko04620	Toll-like receptor signaling pathway	8/201	100/7206	0.00661270178872
ko05164	Influenza A	11/201	167/7206	0.00686216849164
ko05161	Hepatitis B	11/201	173/7206	0.00886242322168
ko05142	Chagas disease (American trypanosomiasis)	9/201	130/7206	0.0102719114427
ko04514	Cell adhesion molecules (CAMs)	9/201	130/7206	0.0102719114427
ko04915	Estrogen signaling pathway	9/201	131/7206	0.0107712289116
ko04810	Regulation of actin cytoskeleton	15/201	264/7206	0.0111989102563
ko05217	Basal cell carcinoma	6/201	68/7206	0.0113846944348
ko04014	Ras signaling pathway	15/201	279/7206	0.0140271178701
ko00590	Arachidonic acid metabolism	5/201	52/7206	0.0144328288921
ko05134	Legionellosis	6/201	74/7206	0.0168068578602
ko05211	Renal cell carcinoma	7/201	96/7206	0.0174145295613
ko04658	Th1 and Th2 cell differentiation	7/201	96/7206	0.0174145295613
ko05140	Leishmaniasis	6/201	75/7206	0.0178576630892
ko04672	Intestinal immune network for IgA production	4/201	37/7206	0.0189029217496
ko04750	Inflammatory mediator regulation of TRP channels	8/201	122/7206	0.0204190920222
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/201	191/7206	0.0218139786514
ko04550	Signaling pathways regulating pluripotency of stem cells	10/201	165/7206	0.0257032612471
ko05212	Pancreatic cancer	6/201	83/7206	0.0279209496622
ko01521	EGFR tyrosine kinase inhibitor resistance	7/201	106/7206	0.0282744296564
ko05221	Acute myeloid leukemia	5/201	63/7206	0.0305854742574
ko05220	Chronic myeloid leukemia	6/201	85/7206	0.0309223778567
ko04218	Cellular senescence	10/201	177/7206	0.0322766145246
ko05210	Colorectal cancer	6/201	86/7206	0.0324992801976
ko05133	Pertussis	6/201	87/7206	0.0341276686521
ko05215	Prostate cancer	7/201	111/7206	0.0351298086051
ko04310	Wnt signaling pathway	10/201	181/7206	0.0353284818872
ko04662	B cell receptor signaling pathway	6/201	88/7206	0.0358080253478
ko04530	Tight junction	12/201	228/7206	0.0364817784063
ko05414	Dilated cardiomyopathy	7/201	112/7206	0.0366222396279
ko05323	Rheumatoid arthritis	6/201	89/7206	0.0375408012861
ko04071	Sphingolipid signaling pathway	9/201	162/7206	0.0467384143957
ko04214	Apoptosis - fly	5/201	72/7206	0.0499487818883